Do AI Symptom Checkers Help or Hinder Timely Care-Seeking for Early Heart Disease? A Narrative Review of the Evidence by Insurance Status

Abstract

Cardiovascular disease killed 919,032 people in the United States in 2023, and how long people wait before getting help shapes much of that toll. The wait is not the same for everyone. In a 24-hospital U.S. registry, 48.6% of uninsured heart attack patients waited more than six hours, compared with 44.6% of insured patients who worried about costs and 39.3% of insured patients who did not. AI symptom checkers now show up at exactly the moment people decide whether to get care. Yet I found no study that measures whether using one changes how fast people seek care for heart symptoms, or whether the answer depends on insurance. This narrative review, organized with guidance from PRISMA 2020, pulls together evidence on four things: how accurate symptom checkers are, how they change people's plans for care, who uses them, and how insurance shapes the decision to seek cardiac care. I searched PubMed/MEDLINE and Google Scholar between June and September 2026, along with publisher, journal, and government websites, and checked the reference lists of key studies. Twenty-two sources form the core evidence base: 20 peer-reviewed studies and 2 survey reports that were not peer-reviewed. Because the studies ranged from simulated-case audits to national registries, I appraised each one with four questions (real patients or simulated cases, observed behavior or stated intention, independence from the tool's developer, and how representative the sample was) and synthesized the findings narratively. Following the Commonwealth Fund, I treated insurance as three levels: adequately insured, underinsured, and uninsured. The evidence cuts both ways. Symptom checkers reduce uncertainty and usually catch emergencies. But in the largest real-world dataset, users lowered the urgency of their care plans eight times as often as they raised it. Most tools triage no better than an average layperson, and in studies with real patients, 2-9% of cases were under-triaged. In a randomized trial, people using AI chatbots made no better care decisions than people using other sources. The typical user is insured, college-educated, and female, so little is known about the groups most likely to delay. I argue that insurance likely decides whether a symptom checker speeds care up or slows it down. Insured users can act on advice, or double-check it, at little cost. Uninsured and underinsured users are the least able to catch a falsely reassuring answer. Three hypotheses follow. Among adequately insured adults, prior symptom checker use will shorten the time to professional consultation for early cardiac symptoms. Among uninsured adults, it will not shorten that time and may lengthen it. Underinsured adults will fall in between, and pairing advice with navigation to low-cost care should narrow the gaps among the three groups. I outline an equity-focused design with measurable safety thresholds, such as sensitivity for emergencies of 95% or higher and harmful under-triage in 2% or fewer encounters, along with community health worker review and community governance. I also propose four studies to test the hypotheses: an audit of standardized cardiac cases, a prospective cohort stratified by insurance tier, a stepped-wedge trial of community health worker navigation, and qualitative interviews.